Jeremy Scott Bredfeldt, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 8 | 2024 | 1329 | 1.320 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 6 | 2023 | 1658 | 0.550 |
Why?
|
Tachycardia, Ventricular | 5 | 2022 | 1285 | 0.540 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2023 | 460 | 0.470 |
Why?
|
Collagen | 3 | 2019 | 2623 | 0.430 |
Why?
|
Cobalt Radioisotopes | 2 | 2021 | 76 | 0.370 |
Why?
|
Whole-Body Irradiation | 2 | 2021 | 423 | 0.340 |
Why?
|
Radiation Oncology | 2 | 2023 | 554 | 0.290 |
Why?
|
Microscopy, Interference | 1 | 2005 | 34 | 0.250 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2258 | 0.240 |
Why?
|
Catheter Ablation | 3 | 2022 | 2711 | 0.230 |
Why?
|
Tattooing | 1 | 2023 | 57 | 0.220 |
Why?
|
Spectrum Analysis, Raman | 1 | 2005 | 234 | 0.220 |
Why?
|
Molecular Biology | 1 | 2005 | 579 | 0.190 |
Why?
|
Radiotherapy Dosage | 5 | 2021 | 2894 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4254 | 0.190 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1895 | 0.190 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2021 | 799 | 0.170 |
Why?
|
Sarcoidosis | 1 | 2024 | 512 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 35797 | 0.160 |
Why?
|
Automation | 2 | 2023 | 581 | 0.140 |
Why?
|
Syndecan-1 | 1 | 2017 | 163 | 0.140 |
Why?
|
Phantoms, Imaging | 2 | 2022 | 2469 | 0.130 |
Why?
|
Heart Conduction System | 1 | 2021 | 1001 | 0.130 |
Why?
|
Electrons | 1 | 2016 | 261 | 0.130 |
Why?
|
Observer Variation | 1 | 2021 | 2574 | 0.130 |
Why?
|
Respiration | 1 | 2021 | 1644 | 0.120 |
Why?
|
Algorithms | 4 | 2022 | 13810 | 0.120 |
Why?
|
Movement | 1 | 2021 | 1466 | 0.120 |
Why?
|
Image Enhancement | 1 | 2005 | 2871 | 0.120 |
Why?
|
Health Plan Implementation | 1 | 2016 | 331 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1529 | 0.110 |
Why?
|
Photons | 1 | 2016 | 584 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5295 | 0.100 |
Why?
|
Tomography, Optical Coherence | 1 | 2005 | 2805 | 0.100 |
Why?
|
Anesthesia | 1 | 2023 | 1554 | 0.100 |
Why?
|
Heart | 2 | 2021 | 4359 | 0.100 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 494 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 712 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2019 | 1711 | 0.090 |
Why?
|
Breast Neoplasms | 2 | 2017 | 20763 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3772 | 0.090 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 930 | 0.090 |
Why?
|
Cardiology | 1 | 2021 | 1676 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2023 | 11215 | 0.080 |
Why?
|
Disease Progression | 2 | 2017 | 13317 | 0.080 |
Why?
|
Quality Control | 2 | 2021 | 820 | 0.080 |
Why?
|
Radiology | 1 | 2021 | 2084 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13218 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3225 | 0.070 |
Why?
|
Neoplasms | 3 | 2021 | 21715 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2165 | 0.070 |
Why?
|
Humans | 24 | 2024 | 746630 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2020 | 4283 | 0.060 |
Why?
|
Software | 2 | 2021 | 4400 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3552 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3173 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2024 | 114 | 0.060 |
Why?
|
Radiometry | 2 | 2019 | 816 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2023 | 5096 | 0.050 |
Why?
|
Radiation Dosage | 2 | 2021 | 1950 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4272 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3057 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3169 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5255 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 382 | 0.050 |
Why?
|
Risk Assessment | 1 | 2021 | 23464 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8443 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2005 | 1148 | 0.040 |
Why?
|
Urethra | 1 | 2021 | 404 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9193 | 0.040 |
Why?
|
Cattle | 1 | 2005 | 3840 | 0.040 |
Why?
|
Workflow | 1 | 2023 | 836 | 0.040 |
Why?
|
Health Facilities | 1 | 2023 | 566 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 53253 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2022 | 772 | 0.040 |
Why?
|
Tumor Burden | 1 | 2023 | 1882 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
Motion | 1 | 2021 | 781 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 4856 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 8902 | 0.040 |
Why?
|
Particle Accelerators | 1 | 2016 | 171 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2021 | 1770 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2075 | 0.030 |
Why?
|
Medical Errors | 1 | 2023 | 1249 | 0.030 |
Why?
|
Brain | 1 | 2022 | 26597 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5685 | 0.030 |
Why?
|
Fibrillar Collagens | 1 | 2014 | 41 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 133 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1782 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1109 | 0.030 |
Why?
|
Female | 5 | 2024 | 382450 | 0.030 |
Why?
|
Male | 5 | 2024 | 351420 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57586 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 2225 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1267 | 0.020 |
Why?
|
Aged | 3 | 2021 | 164383 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2479 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 214618 | 0.020 |
Why?
|
Animals | 3 | 2014 | 166558 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4868 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14543 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2372 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2168 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2021 | 3073 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2020 | 2730 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5831 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2017 | 6226 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3706 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2022 | 78313 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5901 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5142 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6734 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6789 | 0.020 |
Why?
|
Mice | 1 | 2014 | 80251 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 63732 | 0.020 |
Why?
|
Kidney | 1 | 2019 | 6990 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12977 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14124 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3306 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 41390 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7280 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29079 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40534 | 0.010 |
Why?
|
Child | 1 | 2023 | 78492 | 0.010 |
Why?
|
Adult | 1 | 2017 | 215192 | 0.000 |
Why?
|